The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...

FDA approval for RAPIBLYK® (landiolol) for use in pediatric patients with SVT provides first therapeutic option for these ...

At 30 days, bleeding and pacemaker rates were lower than in TRISCEND II, but long-term outcomes are eagerly awaited.

View Adagio Medical Holdings, Inc ADGM stock quote prices, financial information, real-time forecasts, and company news from CNN.

The Evoque system features a trileaflet bovine pericardial valve, mounted in a self-expanding nitinol frame with an ...

Stroke and systemic embolism occur at a low rate after catheter-based atrial ablation and may result in substantial sequelae or even death in certain cases.

Researchers quantify the risk for heart failure among people who screen positive for atrial fibrillation and suggest ECG ...

A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in ...

Your smartwatch atrial fibrillation alert deserves a doctor's visit. New research shows people with AF detected during screening face three times the heart failure risk, with most cases appearing ...

Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.

Heart failure is common in people who have atrial fibrillation detected during screening, according to a presentation today at EHRA 2026 the annual congress of the European Heart Rhythm Association ...